Bվ

Endocrinology

Obesity

More in Obesity

The Data Are Clear: Patients Regain Weight After Stopping GLP-1 Drugs

Other than staying on drug, there's no evidence-based strategy to maintain weight loss

Sep 26, 2024
A computer rendering of boxes of semaglutide injection pens.
'Stop Ripping Us Off': Senate Goes After Ozempic-Maker Over Pricing

Novo Nordisk needs to cut prices, says Sen. Bernie Sanders

Sep 24, 2024
A screenshot of Committee Chair Bernie Sanders speaking during this hearing.
One-Year CGM Cleared; Osteoporosis Lawsuits Revived; Chemicals and Early Puberty

News and commentary from the endocrinology world

Sep 24, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Severe Obesity on the Rise in the U.S.

Nearly 10% of those surveyed reported severe obesity

Sep 24, 2024
A photo of a subject’s waist is measured during an obesity prevention study in Chicago.
What Factors Predict Clinically Meaningful Weight Loss With GLP-1 Agonists?

Researcher discusses weight outcomes for those taking semaglutide or liraglutide

Sep 16, 2024
image
Early Data for GLP-1 Pill; FAERS Tirzepatide Reports; AI Diabetes Voice Screening

More noteworthy research from the EASD 2024 meeting

Sep 13, 2024
EASD over a photo of IFEMA Convention Center in Madrid, Spain.
Opinion
Direct-to-Consumer Drugs: Big Pharma's Digital Health Play

Regulators will need to closely watch this new frontier

Sep 13, 2024
A photo of a woman looking at an image of an antibody on her laptop.
Tirzepatide Yields Greater Weight Loss in Women Than Men

But significant weight loss reported for both

Sep 12, 2024
EASD over a photo of IFEMA Convention Center in Madrid, Spain.
Liraglutide Helped Cut BMI in Kids With Obesity as Young as 6

Saxenda group six times more likely to lose at least 5% of BMI

Sep 10, 2024
EASD over a photo of IFEMA Convention Center in Madrid, Spain.
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win

News and commentary from the endocrinology world

Sep 09, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
New Studies Fuel Debate Over GLP-1 Drugs and Suicide Risk

No link found in nationwide data from Sweden and Denmark and in analysis of STEP trials

Sep 03, 2024
A photo of shadows falling across a Wegovy injection pen.
Meat Types and T2D; Semaglutide in Heart Failure; Acromegaly at the Paralympics

News and commentary from the endocrinology world

Sep 03, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Wegovy Protects Against Deadly COVID Cases

Non-cardiovascular benefits observed in SELECT trial

Aug 30, 2024
ESC over a photo of ExCeL London conference and exhibition center.
T1D Stem Cell Success Story; Lilly's Discount Tirzepatide Vials; Stelo Now Available

News and commentary from the endocrinology world

Aug 27, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
More in Obesity

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

1.00 CME Credits
Leveraging Continuous Glucose Monitoring (CGM) to Improve Outcomes in Type 2 Diabetes

1.50 CME Credits
Breaking Barriers in Obesity Management: Adopting a Holistic Approach to Optimize Health Outcomes

0.50 CME Credits
Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH)

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management